IAC 2020 International AIDS Conference
Virtuel,  Juli 2020

https://www.aids2020.org


Heilung

Der Brasilianische Patient: Heilung oder Hype?

Gewicht  

Nur geringe Zunahme bei Switch auf DOR/3TC/TDF

Weniger Zunahme unter ATV/r vs DTG

Zunahme bei Switch von TDF auf TAF

HIV-Positive nehmen schneller zu als HIV-Negative

Neue Medikamente

Islatravir + Doravirin

Kaspid-Inhibitor Lenacapavir

Antiretroviale Therapie

BICSTaR: B/F/TAF im klinischen Alltag

Hepatitis

HCV-Reinfektion bei MSM

PDF/PPT zum Download ppt pdf

ViiV Healthcare

002901-Efficacy-safety-of-DTG-and-3TC-vs-3-drug-ART-in-na--ve-HIV-1-infected-patients-at-96-week.pptx

002902-Is-DTG-3TC-effective-and-safe-in-clinical-practice--Evidence-from-real-world-data..pptx

002903-Improved-metabolic-parameters-after-switching-from-TAF-based-drug-regimen-to-DTG-3TC--TANGO.pdf

002904-Weight-change-among-treatment-naive-women-initiating-dolutegravir-in-the-ARIA-study..pptx

002905-Viral-replication-at--40c-mL-for-2DR-of-DTG-3TC-vs.3DR-based-on-TAF-in-TANGO.pptx

002906-PRO-through-week-48-of-ATLAS-2M--A-study-of-LA-CAB-and-RPV-every-4-or-8-weeks..pptx

002907-Compassionate-use-of-LA-CAB-and-RPV-for-patients-in-need-of-parenteral-ART.pptx

002908-Implementing-LA-injectable-ART-to-treat-HIV--survey-of-HCPs-from-13-countries-in-ATLAS-2M-..pdf

002909-Model-based-approach-of-dose-selection-and-optimal-PK-of-FOS-for-pediatrics-with-MDR-HIV-1-..pptx

002910-Clinical-outcomes-of-heavily-treatment-experienced-individuals-in-the-OPERA-Cohort..pptx

002911-Factors-associated-with-resilience-among-older-people-living-with-HIV..pdf

002912-To-dose-adjust-or-not-to-dose-adjust--3TC-dose-in-renal-impairment..pptx

002914-A-tale-of-two--U--s-and-their-use-by-HCPs--Analysis-of-information-sharing-about-U-U..pptx

002915-Putting-the-heart-back-into-HAART--HCP-Patient-engagement-is-associated-with-better-HOs.pptx

002917-Nurse-delivered-cognitive-behavioral-therapy-adherence-depressive-symptoms--in-South-Korea.pdf

002918-changing-treatment-concerns-of-older-PLHIV-and-difficulties-patient-provider-communication..pptx

002928-CUSTOMIZE-Study.pptx

002929-Clinical-socio-characteristics-associated-with-poor-health-across-multiple-domains.pptx


Gilead Sciences GmbH

Acosta_BVY-4030-ART-experience-with-resistance---blip-analysis_AIDS2020_PEB0257_Submitted.pdf

Andreatta_BVY-switch-studies---prevalence-and-RF-for-pre-existing-NNRTI-resistance_AIDS2020_PEB0254_Submitted.pdf

Asif--Hill-_Predicted-Risk-of-Adverse-Pregnancy-Outcomes-from-Treatment-Induced-Obesity-in-ADVANCE_AIDS-2020_-2.pdf

Begley_LEN-Sustained-delivery-formulation-supports-q6mo-dosing_AIDS2020_PEB0265_Submitted.pdf

Cox_DISCOVER-PrEP-Deep-Sequencing-Resistance_AIDS-2020_PDB0404.pdf

Ferrario-L_Comorbidities-and-HRQoL-Italy_WAIDS-2020_PED0833.pdf

Gorgos_DISCOVER-PrEP-STI_AIDS-2020_PDB0303.pdf

Imbert_Marginalized-Pop_AIDS2020_Oral_OAE0406.pdf

Natukunda-E.-OABLB0101---Safety--pharmacokinetics-and-efficacy-of-low-dose-ECFTAF-in-VS-children-2-years-.pdf

Ramgopal_Pooled-BVY-W48-in-65yo-and-older_AIDS-2020_OAB0403_Submitted.pdf

Robineau_BICSTaR_BVY-real-world-eff-safety-tolerability-M6_AIDS-2020_PEB0229_Submitted.pdf

Selected-Gilead-Abstracts-AIDS-2020-and-COVID-19-Conference.pptx

Serrano-et-al-Reducing-ART-to-less-than-3-ARV-regimen-linked-to-increased-systemic-inflammation-.pdf

Shalit_DISCOVER-PrEP-Risk-Compensation_AIDS-2020_PEB0165.pdf

Silverbeg_Weight_AIDS2020_Oral0603.pdf

Sokhela_The-ADVANCE-trial_AIDS2020_OAXLB0104.pdf

Wallin-J.-OAB0205---Vesatolimod--a-toll-like-receptor-7--TLR7--agonist--induces-dose-dependent-immune-respons.pdf


Meldungen

Ältere Meldungen weiter

Diese Website bietet aktuelle Informationen zu HIV/Aids sowie zur HIV/HCV-Koinfektion. Im Mittelpunkt stehen HIV-Test, Symptome und Auswirkungen der HIV-Infektion, Behandlung der HIV-Infektion, HIV-Medikamente mit Nebenwirkungen und Komplikationen, Aids, Hepatitis B und C. Ein Verzeichnis der Ärzte mit Schwerpunkt HIV ergänzt das Angebot.